1,600
Views
15
CrossRef citations to date
0
Altmetric
Article

Clinical efficacy and mechanism for focused ultrasound (FUS) in the management of cervical intraepithelial neoplasia 1 (CIN1)

, , , , , & show all
Pages 339-345 | Received 20 Oct 2019, Accepted 24 Mar 2020, Published online: 09 Apr 2020

References

  • National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: cervical cancer (V1. 2016) [EB/OL]. [cited 2015 Nov 25]. Available from: https://www.nccn.org/professionals/physician.gls/pdf/cervical.pdf.
  • Henk HJ, In Sing a. R, Singhal PK, et al. Incidence and costs of cervical intraepithelial neoplasiain a US commercially insured Population. J Low Genit Tract Dis. 2010; 14(1):29–36.
  • Velasco J, Álvarez-Ruiz E, González-Fernández L, et al. Expression of p16/Ki-67 in ASC-US/LSIL or Normal Cytology with Presence of Oncogenic HPV DNA. Anticancer Res . 2015;35:6291–6296.
  • Neerja B, Daisuke A, Daya NS, et al. Cancer of the cervix uteri [J]. Int. J Gynecol Obstet. 2018;143(supp12):22–26.
  • Hu SY, Zhao FH, Ma JF, etc. A prospective cohort study of prognosis of mild cervical intraepithelial neoplasia and its association with human papilloma virus. Chin J Prev Med. 2014;48(5):361–365.
  • Gao BL, Qian P, Ma ZY, etc. Expression and significance of human papilloma virus L1 protein and p16. Ki 67 in Cervical Squamous Epithelial Lesions. Mat Child Health Care China. 2015;30(7):1109–1111.
  • Sari Aslani F, Safaei A, Pourjabali M, et al. Evaluation of Ki – 67, p16 and CK17 markers in differentiating cervical intraepithelial neoplasia and benign lesions. Iran J Med Sci. 2013;38(1):15–21.
  • Malinowski DP. Molecular diagnostic assays for cervical neoplasia: emerging markers for the detection of high-grade cervical disease. Biotechniques. 2005;38(4S):S17–S23.
  • Wang RM, Peng JJ, You ZX. Interpretation of ASCCP 2012 guidelines for cervical cancer screening and management of precancerous lesions (two) [J]. Int J Obstet Gynecol. 2015;42(2):238–240.
  • Petry KU. Management options for cervical intraepithelial neoplasia.[J]. Best Pract Res Clin Obstet Gynaecol. 2011;25(5):641–651.
  • Zhang L, Zhang W, Orsi F, et al. Ultrasound – guided high intensity focused Ultrasound for the treatment of gynecological diseases: a review of safety and efficacy[J]. Int J Hyperthermia. 2015;31(3):280–284.
  • Poissonnier L, Chapelon JY, Rouviere O, et al. Control of prostate cancer by transrectal HIFU in 227 patients. Eur Urol. 2007;51(2):381–387.
  • Ye M, Deng X, Mao S, et al. High intensity focused ultrasound treatment for non-neoplastic epithelial disorders of the vulva: factors affecting effectiveness and recurrence. Int J Hyperthermia. 2015;31(7):771–776.
  • Li C-Z, Wang Z-B, Yang X, et al. Feasibility of focused ultrasound therapy for recurrent cervicitis with high-risk human papillomavirus infectionet. Ultrasound Obstet Gynecol. 2009;34(5):590–594.
  • Lin C, Yang J, Li CZ, etc. Treatment of low grade cervical intraepithelial neoplasia with focused ultrasound. Chin Int Imag Thera. 2012;12(9):873–876.
  • Chen J, Zhou D, Liu Y, et al. A comparison between ultrasound therapy and laser therapy for symptomatic cervical ectopy. Ultrasound Med Biol. 2008;34(11):1770–1774.
  • Cao ZY. Obstetrics and Gynecology. Beijing: People’s Medical Publishing House; 2010. 567.
  • Ren YF, Wu FY, Cai HF, etc. the comparison of curative effect for Focused ultrasound and laser power with electric coagulation for treating CIN I patients with high-risk human papilloma virus infection. J Third Military Med University. 2012;34(4):350–353.
  • Lesnikova I, Lidang M, Hamilton-Dutoit S, et al. P16 as a diagnostic marker of cervical neoplasia: a tissue micmarray study of 796 archival specimens. Diagn Pathol. 2009;4(1):22.
  • Cortecchia S, Galanti G, Sgadari C, et al. Follow -up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16 Ink 4a. Int J Gynecol Cancer. 2013;23(9):1663–1669.
  • Reuschenbach M, Seiz M, von Knebel Doeberitz C, et al. Evaluation of cervical cone biopsies for coexpression of p16 INK 4a and Ki – 67 in epithelial cells. Int J Cancer. 2012;130(2):388–394.
  • Bean SM, Eltoum I, Horton DK, et al. Immunohistochemical expression of p16 and Ki – 67 Correlates with degree of anal intraepithelial neoplasia. Am J Aurg Pathol. 2007;31(4):555–561.
  • Lu JY, Qin WP. The clinical significance of p16 and Ki – 67 in cervical lesions. Chin General Practitioner J. 2011;189(3):81–88.
  • Calil LN, Edelweiss MI, Meurer L, et al. p16 INK 4a and Ki – 67 expression in normal dysplastic and neoplastic uterine cervical epithelium and human papilloma virus (HPV) infection. PatholRes Pract. 2014;210(8):482–487.
  • Wu SF, Zhang JW, Qiu M, etc. Expression and relationship of survivin fas and fasl in cervical carcinoma. J Shanghai Jiao Tong University (Medical Edition). 2010;30(9):1138–1142.
  • Li C, Xiong X, Li Y, et al. Therapeutic effects of focused ultrasound in 4014 patients with symptomatic cervical ectopy. Ultrasound Med Biol. 2013;39(4):604–610.
  • Duan J, Li HY, Xiong J, et al. Comparative analysis of clinical efficacy of microwave and focused ultrasound in the treatment of CIN I. Public Health Prevent Med. 2010;21(6):124–125.
  • Zhang B, Xu DM, Su XR. Efficacy of leep and focused Ultrasound in the treatment of CIN I with High risk HPV infection.China Med Eng. 2014;22(5):134–135.